Merck Faces Multiple Challenges: Will It Steer Through Successfully?Zacks Investment Research • 07/09/25
Merck to Acquire Verona Pharma, Expanding its Portfolio to Include Ohtuvayre® (ensifentrine), a First-In-Class COPD Maintenance Treatment for Adults and Expected to Drive Growth into the Next DecadeBusiness Wire • 07/09/25
Meck looks to soften impact of Keytruda cliff with $10bn tilt for Verona PharmaProactive Investors • 07/09/25
Merck to Present New Data Highlighting Research Advancements Across its HIV Prevention and Treatment Pipeline at IAS 2025Business Wire • 07/08/25
Merck Mercuriadis plots return with new Hipgnosis venture after market reboundProactive Investors • 07/07/25
MRK Pins Hopes on New PAH Drug Winrevair Amid Looming Keytruda LOEZacks Investment Research • 07/03/25
FDA Grants Priority Review for WINREVAIR™ (sotatercept-csrk) to Update Label Based on Results From ZENITH TrialBusiness Wire • 07/02/25
Merck Foundation Chairman, CEO, and 14 First Ladies Inaugurate the 7th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit in DubaiBusiness Wire • 07/01/25